Eligibility Criteria Studies were eligible if they evaluated BPC-157, thymosin beta-4 or marketed derivatives (including TB-500), GHK-Cu, or other peptide-based agents commonly promoted for musculoskeletal healing or recovery and reported outcomes relevant to musculoskeletal pathology, orthopaedic surgery, postoperative recovery, or perioperative risk domains
They clearly dropped nootropics from their priorities and realized that the demands of the peptide community and much more lucrative (and we dont blame them)
This means 34 states won't cover these medications when prescribed solely for weight management
TOC TOC was considered not meaningful because benzyl alcohol itself creates a large organic load and overwhelms the signal
This dual peptide blend pairs BPC-157 and TB-500 in a single lyophilised vial with 5mg of each, supplied as a high purity, COA verified powder for laboratory research